For decades, antidepressant treatment has largely relied on trial and error, with many patients cycling through medications before finding one that works. New research published July 6 in Nature Mental Health suggests that biological and behavioral markers may help clinicians make more informed prescribing decisions, potentially improving response rates for people with major depressive disorder.
Valerie A. Canady (Sat,) studied this question.